3D bioprinting is beginning the shift from pure research into applied research and the sale of commercial products, with Organovo officially selling its 3D printed liver assays and inking a deal with L’Oreal to develop 3D printed skin for cosmetic testing. Consumer goods giant Procter & Gamble has, after taking on A.G. Lafley as their Chairman of the Board, President, and CEO and dropping about 100 brands, experienced a revitalization of their business, seeing stock prices steadily climb over the course of Lafley’s leadership. …
The original post P&G Jumps into 3D Bioprinting with Singapore Grant Competition appeared first on 3D Printing Industry.